Atea Pharmaceuticals: Q1 Earnings Insights

Atea Pharmaceuticals AVIR reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Atea Pharmaceuticals beat estimated earnings by 12.07%, reporting an EPS of $-0.51 versus an estimate of $-0.58.

Revenue was down $65.98 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $1.17 which was followed by a 1.89% increase in the share price the next day.

To track all earnings releases for Atea Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.